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ABSTRACT 
Background/Aims: Advanced glycation end products (AGEs), which are linked to 
both aging and hyperglycemia, cause marked functional and structural alterations in 
human skin. The metabolism of glucose is closely associated with that of fatty acids 
(FAs), which share the same energy yielding reaction pathways; however, the effects of 
AGEs on epidermal FA metabolism remain unclear. Methods: Ceramide, cholesterol 
and FA content in a reconstructed epidermal model glycated by glyoxal was analyzed by 
high performance thin layer chromatography. FA species extracted from HaCaT 
keratinocytes were identified by gas chromatography-mass spectrometry. Regulation of 
FA synthesis was analyzed by real-time PCR. For physical analysis, excised mouse skin 
was glycated using a vertical diffusion cell and used for evaluation of barrier function 
by assessment of transepidermal water loss and observation of sodium fluorescein 
penetration. Results: Saturated FA content was significantly increased in glycated 
epidermis, and glycation upregulated mRNA expression of FA elongase 2 and 3 and FA 
synthase in HaCaT cells. Furthermore, both inside-out and outside-in barrier functions 
were disrupted in glycated, excised skin. Conclusion: Biological and physical changes 
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in the epidermis, especially the upregulation of FA synthesis by glycation, contributed 
to barrier disruption.  
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INTRODUCTION 
Advanced glycation end products (AGEs), which are generated via the 
non-enzymatic Maillard reaction between the aldehyde group of reducing sugars and 
amino group of proteins, lipids or nucleic acids [1, 2], accumulating in aged or 
diabetes-conditioned tissue [3, 4] AGEs have been detected in both the epidermis and 
dermis [4, 5] and cause significant functional and structural alterations in human skin. 
Since striking characteristics of AGEs, yellowish tint and autofluorescence affect skin 
appearance, anti AGEs strategy to skin attract much attention in recent years.  
Epidermal glycation causes decrease in water content of the stratum corneum (SC) and 
glycation of collagen and elastic fibers is considered as one of the causes of degradation 
of dermal extra cellular matrix [6, 7, 8] . Additionally, AGEs also induce biological 
reactions via binding to the receptor for AGEs (RAGE) [9]. RAGE signal transduction 
induces activation of nuclear factor kappa B (NF-κB) and subsequent transcription of 
proinflammatory genes, including interleukin 1 (IL-1), tumor necrosis factor alpha 
(TNFα)matrix metalloproteinases (MMPs) and RAGE itself, accelerating further skin 
senescence and deconstruction [10, 11] 
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The metabolism of glucose is closely associated with that of fatty acids (FAs) 
because both substrates share the same energy yielding reaction pathways, which 
involve the accumulation of acetyl CoA. Recent studies show that excess lipid 
accumulation in non-adipose tissue is associated with cytotoxicity [12, 13]. FAs are 
simple lipids, which form part of phospholipids, triacylglycerol and ceramides, and 
exist ubiquitously in cells as essential constituents of the cell membrane and as 
important substrates for energy metabolism. FAs are produced by degradation of more 
complex lipids or are newly synthesized from the conversion of 
Acetyl-CoA/Malonyl-CoA to palmitic acid by fatty acid synthase (FASN). The fatty 
acid elongase (ELOVL) family of proteins is the most well characterized group of 
enzymes for FA elongation in the generation of very long chain fatty acids [14]. 
Interestingly, the SC has a unique lipid composition: it consists of FA, ceramides 
(CERs) and cholesterol (CHOL) in an approximately equimolar ratio. These lipids have 
an essential role in the barrier function of the skin and are produced in viable epidermis.  
Despite the strong relationship between glucose and FA metabolism, the 
effects of glycation on skin FAs and barrier function are currently not well studied. Thus, 
6 
 
we focused on the relationship between glycation and intercellular lipids and glycation’s 
effect on the barrier function of the skin.  
In this study, we determined that FA content was increased via upregulation of 
FASN and ELOVL expression by glycation of epidermal keratinocytes. Furthermore, 
changes in the ratio of epidermal lipid components, as well as structural alterations, 
resulted in barrier disruption in skin.  
 
MATERIALS AND METHODS 
Reagents 
Glyoxal (GO), cholesterol and palmitic acid were purchased from Wako Pure 
Chemical Industries, Ltd. (Osaka, Japan). An antibody specific for AGEs (6D12) was 
purchased from TransGenic Inc. (Fukuoka, Japan). Alexa 546-conjugated secondary 
antibody was purchased from Life Technologies (Carlsbad, CA, USA). Thiazolyl blue 
tetrazolium bromide (MTT) was purchased from Sigma-Aldrich (St. Louis, MO, USA). 
For lipid standards, ceramide NS and AS were purchased from Matreya (State College, 
PA, USA) and ceramide NP and AP were purchased from Evonic Industries AG (Essen, 
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Germany). Gas chromatography-mass spectrometry standard F.A.M.E. Mix RM-3 was 
purchased from Sigma-Aldrich. 
 
Cell culture 
The immortalized human skin keratinocyte cell line HaCaT was maintained in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine 
serum and incubated in a humidified atmosphere of 5% CO2 at 37°C. AGEs were 
induced by GO. After 30 min of exposure to GO in culture medium, cells were washed 
twice with culture medium and fresh culture medium added. 
The reconstructed epidermal model (Labcyte EPIMODEL) was purchased from 
JTEC (Gamagori, Japan) and maintained in the supplied culture medium. AGEs were 
induced by exposure to various concentrations of GO for 72 h from the basal side. 
 
Cell viability assay 
HaCaT keratinocytes were cultured for 24 h before exposure to various 
concentrations of GO. After 48 h incubation, cells were washed and incubated with 0.5 
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mg/mL MTT in culture medium for a further 4 h. The resulting formazan crystals were 
solubilized in 150 μL of 0.04 M hydrochloric acid/isopropyl alcohol. The absorbance at 
570 nm was measured using a microplate reader (SpectraMax M2e; Molecular Devices, 
Sunnyvale, CA, USA).  
 
RNA extraction and quantitative real time PCR 
Total RNA was isolated from HaCaT cells using RNAiso Plus (Takara Bio, Otsu, 
Japan), followed by reverse transcription to cDNA using PrimeScript® RT reagent kit 
(Takara Bio) using a thermal cycler (Veriti; Applied Biosystems, Foster City, CA, USA). 
Real-time PCR reactions were performed using SYBR® Premix Ex Taq™ (Takara Bio) 
using a StepOnePlus™ analyzer (Applied Biosystems) with the indicated primers (Table 
S1). The fold-change of expression was calculated according to the ΔΔCT method using 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an endogenous control. 
 
Immunocytochemistry 
HaCaT cells were cultured on glass slides (Fisher Scientific UK Ltd., Loughborough, 
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UK) prior to the induction of glycation with GO. After 48 h incubation, cells were 
washed twice with PBS and fixed with ice cold methanol for 15 min at −30°C. 
Nonspecific staining was blocked by pre-incubation with 1% bovine serum albumin in 
PBS for 1 h at room temperature. For primary antibody reactions, cells were incubated 
with the antibody against AGEs at a 1:200 dilution in Can Get Signal immunostain® 
Solution A (Toyobo, Osaka, Japan) overnight at 4°C. Bound antibodies were visualized 
with Alexa 546-conjugated secondary antibody at a 1:200 dilution in Can Get Signal 
immunostain® solution A for 1 h at room temperature. After washing, Hoechst 33258 
(Dojindo Laboratories, Mashiki, Japan) was added for nuclear counterstaining. All 
images were obtained using an IX71 microscope (Olympus, Tokyo, Japan). 
 
Lipid extraction 
For lipid extraction from HaCaT cells, 4 × 105 cells were plated on 6 cm plates. 48 h 
after exposure to GO, lipids were extracted according to the method of Bligh and Dyer 
with slight modifications [15]. Briefly, cells were washed and scraped from dishes into 
1.2 mL of ddH2O. To lyse cells completely, cell suspensions were sonicated. The protein 
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content of the lysate was quantified by the conventional Lowry method. Three mL of 
each of CHCl3 and MeOH were added to the cell suspension before further sonication. 
Then samples were filtrated and 1.5 mL of ddH2O added, followed by centrifugation at 
215 g for 20 min. The lower layer was collected and dried under a N2 stream and used 
as lipid samples.  
Epidermal lipid samples from the reconstructed epidermal model were extracted in 
CHCl3/MeOH 2:1 (v/v) solution after being washed and excised from the transwell. 
Samples were minced, sonicated for 10 min, and then the solution filtered and dried 
under a N2 stream. All lipid extracts and standards were dissolved in CHCl3/MeOH 2:1 
(v/v) solution.  
 
High performance thin-layer chromatography (HPTLC) analysis 
10 L of lipid extracts were applied to the HPTLC plate (HPTLC silica gel 60, 
Merck KGaA; Darmstadt, Germany) together with lipid standards to generate 
calibration curves and the plate was developed twice in a saturated chromatographic 
chamber containing CHCl3/MeOH/CH3COOH 190:9:1 (v/v/v) mobile phase. Then the 
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HPTLC plate was dried and sprayed with a reagent (10% CuSO3, 8% H3PO4 aqueous 
solution) and heated to 180°C for 10 min and quantitated by densitometry using Image J 
(National Institutes of Health, Bethesda, MD, USA).  
 
Gas chromatography-mass spectrometry analysis 
 FA species were analyzed as described previously, with slight modification 
[16, 17]. The free FA fraction was isolated from total lipids by HPTLC, followed by 
methyl esterification using odd‐numbered fatty acid as an internal standard. Then 
derivatives were analyzed by gas chromatography (HP6890 series GC system; Hewlett 
Packard, Palo Alto, CA, USA)-mass spectrometry (JMS700; JEOL, Tokyo, Japan) on a 
Restek RTX-5 column (30 m × 0.25 mm i.d., 0.25 m d.f.; Restek Corp., Bellefonte, PA, 
USA). The initial temperature was 110°C, with a 10°C increase each min, up to 300°C. 

Animals 
Seven- to ten-week-old male hairless mice (Hos: HR-1) were purchased from 
Hoshino Experiment Animal Center (Bando, Japan). All animal experiments were 
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carried out in accordance with the guidelines of, and approved by, the Animal Research 
Committee of Josai University.  
 
Induction of glycation and penetration experiments 
Skin samples removed from mice and cleaned of subcutaneous tissue and fat 
were mounted on vertical diffusion cells. The cells used in this study had an effective 
diffusion area of 1.77 cm2 and a receptor compartment volume of 5.0 mL. For induction 
of glycation, the skin specimens were hydrated with PBS (control) or PBS containing 
50 mM GO for 24 h. Glycation was induced from the basal side. The receptor fluid was 
maintained at 32°C, and continuously agitated with a magnetic stirrer bar.  
For imaging of FL-Na penetration, skin specimens were removed from the 
diffusion cells after application of 1 mM of FL-Na to the SC side for 0 h, 1 h, and 6 h, 
and the SC surface was washed 7 times with purified water. Skin specimens were 
embedded in Optimal Cutting Temperature compound (Sakura Finetek Japan Co. Ltd., 
Tokyo, Japan), snap-frozen in liquid nitrogen, and cut into 20-μm-thick sections. All 
images were obtained using an IX71 microscope (Olympus, Tokyo, Japan). Signal 
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intensity was determined using the ImageJ Histogram tool.  
 
Measurement of transepidermal water loss (TEWL) 
Cutaneous water evaporation was measured with a VAPOSCAN 
AS-VT100RS (Asahi biomed, Yokohama, Japan). To measure excised skin, the skin 
surface temperature was kept at 37°C in the diffusion cells to obtain a stable TEWL 
value. Reconstructed epidermal models were acclimatized for 1 h before measurement. 
 
Measurement of skin color 
Skin color was measured using a chromameter CR-400 (Konica-Minolta, 
Tokyo, Japan). Measurement of skin samples was performed after placing the skin 
samples on a white board. Data are expressed in the L*a*b* color space, and the 
parameter b* was employed as the value for the yellowish tint. 
 
Data analysis 
Statistical differences between groups were assessed by means of Dunnett’s 
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test or 2-tailed Student t-test using SAS statistics software (SAS Institute, Cary, NC, 
USA) and a P value of < 0.05 was considered as the limit of statistical significance. 
Testing of correlation coefficients was conducted using Microsoft Excel 2011 
(Redmond, WA, USA). 
 
RESULTS 
The composition lipids is changed in the glycated reconstructed epidermal model  
We first evaluated the component ratio of SC intercellular lipids in the 
glycated epidermis. We used a reconstructed epidermal model and determined the 
quantity of FA, CERs, and CHOL. The content of FA in normal and 10 mM GO 
exposed reconstructed epidermis was 14.0 mg/cm2 and 54.4 mg/cm2 respectively, with 
GO inducing a 3.9-fold increase in FA content in glycated epidermis (Fig. 1f, P < 0.001). 
Concentration dependency was not observed in the content of various CERs or CHOL 
(Fig. 1a–e), thus the component ratio of intercellular lipids was changed as shown in Fig. 
1g. The TEWL value increased significantly (P < 0.001) after 72 h of exposure to GO 
(Fig. 2). 
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Fig. 1 
Fig. 2 
Glyoxal-induced glycation affects the viability of HaCaT cells 
To evaluate the effect of glycation on the skin at early stages of epidermal 
differentiation, we used HaCaT keratinocytes. The viability of HaCaT cells 48 h after 
exposure to 1.25 mM GO for 30 min was 86.2% (P < 0.001, Fig. 3a) and was decreased 
in a GO concentration-dependent manner. The fluorescence intensity derived from 
AGEs was significantly increased by exposure to 5 mM GO, as assessed by 
immunocytochemistry. This result shows that 30 min exposure to 5 mM GO was 
enough to induce glycation in cells 48 h after exposure (Fig. 3b and c). 
Fig. 3 
Glycation accelerates free fatty acid production in HaCaT cells 
We next measured the content of various lengths of FA in glycated HaCaT 
cells. The amounts of C14:0, C16:0, C18:0, and C20:0 contained in lipid extracts from 
normal HaCaT cells were 0.28, 12.7, 10.0, 0.08 g/mg (protein) respectively, while 
those from glycated HaCaT cells were 0.46, 27.9, 21.1, 0.12 g/mg respectively (P < 
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0.05, P = 0.07, P < 0.05, P < 0.05) (Fig. 3d). These results indicate that the production 
of saturated FAs was accelerated by cellular glycation. 
 
An increase in FASN and ELOVL mRNA expression upregulates glycation-induced FA 
accumulation. 
To address whether the increase in FA was derived from de novo synthesis, we 
examined FASN and ELOVL mRNA expression in glycated HaCaT cells. FASN 
contributes to the production of C16, while ELOVL contributes to that of C<16. Of the 
ELOVL family, ELOVL2 and ELOVL3 were upregulated 18.3- and 8.9-fold respectively 
in glycated HaCaT cells 6 h after exposure to GO (P < 0.001, Fig. 4a–g). Additionally, 
FASN expression was increased 2.7-fold after 48 h GO treatment (P < 0.05, Fig. 4 h).  
Fig. 4 
The excised glycated skin model has decreased inside-out and outside-in barrier 
functions  
The physical barrier integrity of skin was investigated using excised glycated 
skin to evaluate biological and physical changes in the SC. The excised glycated skin 
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model demonstrated a yellowish tint in a GO concentration-dependent manner (Fig. 5a). 
TEWL levels of each sample were measured under hydrated conditions at 37°C. 
Correlation between TEWL levels and b* value in glycated skin was observed as shown 
in Fig. 5b, but not significantly so, with r = 0.47 (P = 0.07).  
To determine the migration distance from the SC in normal and glycated skin, 
we investigated the skin penetration of FL-Na (MW: 376.28 Da). One h after 
application, FL-Na was distributed to the SC and observed in all layers of the skin in 
excised, glycated skin (Fig. 5c). In contrast, there was minimal distribution of FL-Na to 
the SC in normal skin. After 6 h, the distribution of FL-Na to the SC was increased in 
both groups. However, excised glycated skin showed higher-intensity staining, 
especially in the SC (Fig. 5d). These results suggest that changes in the structure of the 
SC by glycation disrupted barrier function and increased penetration of FL-Na across 
the skin.  
Fig. 5 
DISCUSSION 
 In the present study, we clarified the effect of glycation on the composition, 
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metabolism and barrier function of epidermal lipids. The most striking feature in the 
epidermal lipid profiles of glycated skin was the increase of various lengths of FAs (Fig. 
1), suggesting the involvement of de novo synthesis of FA, via FASN and ELOVL 
upregulation (Fig. 4). FAs with chain lengths of up to C16 are synthesized by the FASN 
complex, and the ELOVL family of proteins elongates them. Among the seven 
mammalian homologues (ELOVL1–7), ELOVL 3 and 4 are highly expressed in skin 
[14, 18]. Thus, upregulation of ELOVL3 in glycated cells can explain the increase of 
various lengths of FAs in HaCaT cells (Fig. 3). In skin stratum granulosum, FAs are 
thought to be produced via PLA2 from phospholipids to control skin pH [19]. In the 
present study, we used HaCaT cells because they represent the stratum basale of the 
skin. Notably, treatment with bromophenacyl bromide, an inhibitor of PLA2, did not 
affect the FA content in HaCaT cells (data not shown). Taken together, these results 
suggest that FA metabolism might be differentially regulated in differentiating versus 
proliferating keratinocytes. Also, ceramidase or ceramide synthase activity may affect 
FA content. The reconstructed epidermal model will be useful to further determine the 
role of PLA2 or other enzymes in glycated skin. 
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One unsolved question is why FASN and ELOVL were upregulated in glycated skin 
(Fig. 4). Exposure to excess glucose metabolites is known to contribute to the 
upregulation of lipid synthesis in many types of cells, with primary regulators of lipid 
synthesis including liver X receptors, sterol regulatory element-binding protein-1c, and 
carbohydrate response element binding protein transcription factors [20-22]. Further 
investigation is needed to clarify the contribution of these various pathways; however, 
these mechanisms may also be applicable to keratinocytes. 
There are several mechanisms through which the TEWL value was affected (Fig. 2 
& 5). One possible mechanism may involve changes in the physiological properties of 
SC intercellular lipids caused by an increasing FA to ceramide or cholesterol ratio. 
Another possible mechanism is cytotoxicity from saturated lipids, which were 
significantly increased in glycated HaCaT cells. FA-induced apoptosis is specific for the 
saturated FAs (C16:0 and C18:0) and does not occur with C4–C14, either saturated or 
unsaturated [23, 24]. Listenberger et al. reported that palmitate caused cell death, not 
via ceramide synthesis, but via reactive oxygen species (ROS) production in Chinese 
hamster ovary cells [12]. Consistent with this finding, our data also did not show an 
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increase in ceramide content; furthermore, previous studies in which ROS were 
generated in the advanced glycation process support the hypothesis that ROS contribute 
to FA-induced apoptosis in the epidermis [25]. 
We investigated the effect of glycation-induced alteration of the SC structure using 
excised skin and showed that both inside-out and outside-in barrier functions were 
disrupted by the induction of glycation (Fig. 5). It is well documented that percutaneous 
penetration occurs thorough intracellular, transcellular, and to a lesser extent, 
appendageal routes [26]. Notably, the major route of diffusion of hydrophilic molecules 
is across the polar head of the lipid. Because hydrophilic compounds show higher 
permeation in glycated skin, it is thought that modification of the polar head of 
intercellular lipids by AGEs derived from GO causes barrier disruption. This then leads 
to an increase in the penetration rate, as previously documented in permeation across 
excised, glycated skin [27]. In conclusion, not only physical changes in the epidermis, 
but biological alteration, especially upregulation of FA synthesis by glycation, 
contributed to barrier disruption. In future, inhibiting glycation and normalization of FA 
metabolism may offer an alternative treatment for aged or glycated skin.  
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FIGURE LEGENDS 
Figure 1 Changes in the content of epidermal lipids in the reconstructed epidermal 
model after 96 h exposure to glyoxal as determined by high performance thin layer 
chromatography: ceramide (CER)[NS] (a), CER[NP] (b), CER[AS] (c), CER[NH] (d), 
cholesterol (Chol) (e), fatty acid (FA) (f), and total lipid (g). All results are expressed as 
the mean ± S.D. of n = 3 replicates. * P < 0.05, ** P < 0.01, *** P < 0.001. 
 
Figure 2 Transepidermal water loss of the reconstructed epidermal model after 96 h 
exposure to glyoxal: 0 h (a), 24 h (b), 48 h (c), 72 h (d). All results are expressed as the 
mean ± S.D. of n = 3 replicates. *** P < 0.001. 
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Figure 3 Viability of HaCaT cells 48 h after 30 min exposure to glyoxal as determined 
by MTT assay (a). Immunohistochemical analysis for advanced glycation end-products 
(AGEs) under the same conditions as Fig. 3a (b), the signal intensity derived from 
AGEs was divided by the cell number, both calculated using ImageJ (c). The content of 
various lengths of fatty acids as determined by gas chromatography-mass spectrometry. 
Lipids were extracted from HaCaT cells exposed to 0 mM (control), or 5 mM (AGEd) 
glyoxal (GO) for 30 min followed by 48 h incubation. (d) Cell viability is expressed as 
the mean ± S.D. of n = 4 replicates. The other results are the mean ± S.D. of n = 3 
replicates. * P < 0.05, *** P < 0.001. 
 
Figure 4 Changes in the expression of fatty acid synthesis related genes as determined 
by real-time PCR. mRNA levels of ELOVL1–7 (a–d), and fatty acid synthase (FASN) 
(f), expressed as ratios to the endogenous control glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH). All results are expressed as the mean ± S.D. of n = 3 
replicates. * P < 0.05, *** P < 0.001. 
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Figure 5 Inside-out and outside-in permeability across an excised glycated skin model. 
Macroscopic view of excised hairless mouse skin after incubation with various 
concentrations of glyoxal (GO) (a). Transepidermal water loss of excised skin with 
corresponding b* values after exposure to various concentrations of GO (b). Penetration 
pattern of sodium fluorescein (FL-Na) across normal and glycated skin at the indicated 
time points (c) and vertical intensity derived from FL-Na at an arbitrary line calculated 
using ImageJ (d). Glycation was induced by hydration with 50 mM of GO in PBS at 
32°C or 37°C (for TEWL measurement) for 24 h.  
 
Table S1: Sequences of primers 
gene sequence (5' to 3')
ELOVL1 Forward TGGCACTCTCCCTCTACATTGTCTA
Reverse TGAACTTGGAGAAGAGGAAGAGC
ELOVL2 Forward TCTGCTCTCAATATGGCTGGGTAA
Reverse GCGCTGGTAAGATCTTGACACTGTA
ELOVL3 Forward GCCCTATAACTTCGAGCTGCTGTCCAA
Reverse CCACAGCGATGAGAACCAGGTA
ELOVL4 Forward GGCATGCAGTCATGAGAATTACAGA
Reverse GGGAACCAGTACAGAATGTTCACAA
ELOVL5 Forward GATTGCCTATTTACCGTTTGACAGA
Reverse TTTAGACCCTGGCAACCAGTTC
ELOVL6 Forward TGCTAAGCAAAGCACCCGAAC
Reverse CAGGAGCACAGTGATGTGGTGA
ELOVL7 Forward TTGGGACCAAAGCTCATGGAA
Reverse AAAGCTGTGGGTGACCGTGAATA
FASN Forward TATGCTTCTTCGTGCAGCAGTT
Reverse GCTGCCACACGCTCCTCTAG
GAPDH Forward GAAGGTGAAGGTCGGAGT
Reverse GAAGATGGTGATGGGATTTC
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